In line with this, a study by Azzaoui et al. in newly diagnosed DLBCL patients demonstrated significantly increased numbers of circulating PMN-MDSCs (Lin−HLADR−CD33+CD11b+) and M-MDSCs’ (CD14+HLADRlow) frequencies compared to healthy controls [97]. The gene discussed is CD14; the disease is diffuse large B-cell lymphoma.